Literature DB >> 2207013

Hematin therapy in late onset congenital erythropoietic porphyria.

J M Rank1, J G Straka, M K Weimer, I Bossenmaier, B L Taddeini, J R Bloomer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2207013     DOI： 10.1111/j.1365-2141.1990.tb07809.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Targeting heme oxygenase-1 in vascular disease.

Authors:  William Durante
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

2.  Heme status affects human hepatic messenger RNA and microRNA expression.

Authors:  Herbert L Bonkovsky; Weihong Hou; Nury Steuerwald; Qing Tian; Ting Li; Judy Parsons; Alicia Hamilton; Sunil Hwang; Laura Schrum
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

3.  Adult-onset congenital erythropoietic porphyria (Günther's disease) presenting with thrombocytopenia.

Authors:  A Murphy; G Gibson; G H Elder; B A Otridge; G M Murphy
Journal:  J R Soc Med       Date:  1995-06       Impact factor: 5.344

Review 4.  Protective role of heme oxygenase-1 against inflammation in atherosclerosis.

Authors:  William Durante
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.